https://pharmaceuticaldaily.com/ec-approves-marketing-to-vitor-pharmas-veltassa-for-hyperkalaemia/
EC approves marketing to Vitor Pharma’s Veltassa for hyperkalaemia – pharmaceutical daily
Jul 21, 2017 - The European Commission has approved patriometer to be marketed as Veltassa in the 28 EU countries for treating hyperkalaemia in adult patients.
approvesmarketingvitorveltassahyperkalaemia
https://www.veltassa.com/hcp/veltassa-distributors
VELTASSA Distributors | VELTASSA® (patiromer)
Review a list of authorized wholesale distributors and specialty pharmacies authorized for VELTASSA® (patiromer) potassium binder. See full Prescribing Info.
veltassadistributorspatiromer
https://fass.se/product/20160420000029
Veltassa (Pulver till oral suspension 16,8 g) • Översikt | FASS Patient
Information till användaren om Veltassa, Pulver till oral suspension 16,8 g från Vifor Pharma (NPL-id: 20160420000029) | FASS Patient
veltassapulvertilloralsuspension